Merck, Pfizer keep high-flying vaccine sales intact with key CDC backing

Merck and Pfizer faced uncertainty on big-selling vaccines going into this week’s meeting of the Advisory Committee on Immunization Practices, a CDC panel that sets U.S. vaccination policy. But in votes on Wednesday, the panel either maintained favorable recommendations for the vaccines, or in Merck’s case, expanded recommendations. ACIP expanded its recommendation for Merck’s HPV vaccine Gardasil 9 to men and women aged 27 through 45 who aren’t adequately vaccinated.
Read more...

;